评估潜在的新型甘油三降低药物的长期类效应,使用孟德尔随机化确定的变体
Elliot Outland1, Yi Xin1,2, Alyson L Dickson3
1Department of Biomedical Informatics, Vanderbilt University Medical Center, Nashville, TN.
medRxiv : the preprint server for health sciences
|September 18, 2025
概括
准与甘油三酸 (TG) 相关的基因显示出潜在的心血管益处. 然而,这些遗传点可能对非洲祖先的个人来说不那么有效,在祖先之间观察到的额外好处有限.
科学领域:
- 遗传学 是一个遗传学.
- 心血管疾病 心血管疾病
- 药物基因组学 药物基因组学
背景情况:
- 三甘油 (TG) 相关基因为改善心血管结果提供了潜在的治疗点.
- 对于针对这些基因的具体好处或风险,人们的理解有限.
研究的目的:
- 研究欧洲血统 (EA) 和非洲血统 (AA) 队列中TG水平和验证的TG相关遗传变异之间的关联.
- 评估针对TG相关基因的潜在副作用和心血管益处.
主要方法:
- 在范德比尔特大学的BioVU数据库中使用了PheWAS (Phenome-Wide Association Studies),用于EA和AA队列.
- 在EA和AA参与者中复制了我们所有人 (AoU) 研究计划中的发现.
- 从孟德尔随机化研究中测量TG水平和验证的单核酸多态 (SNP) 之间的相关性进行了测试.
主要成果:
- 在EA群体 (BioVU和AoU) 中,10个验证的SNP中有9个显示出与脂质和心血管表型的显著关联.
- 在AA队列 (BioVU和AoU) 中,结果有限,只有6个验证的SNP中的1个显示出显著的关联,在两个队列中没有一致的发现.
- 在EA或AA BioVU患者中检测到很少的副作用,没有复制的发现.
结论:
- 针对已知的TG相关基因可能提供有限的额外益处,并对降低心血管风险产生很少的有害影响.
- 这些遗传标可能在减轻非洲血统个人心血管风险方面表现出较低的有效性.
相关概念视频
Lipid-Lowering Drugs: Statins and Miscellaneous Agents
1.3K
Hyperlipidemia, a medical condition often referred to as high cholesterol, is characterized by abnormally elevated levels of lipids in the bloodstream. When present in excess, these lipids, specifically cholesterol and triglycerides, can lead to serious health complications, often involving cardiovascular diseases. Illnesses like atherosclerosis, heart attacks, and pancreatitis have all been linked to untreated hyperlipidemia. This means controlling and regulating cholesterol and triglyceride...
1.3K
Atherosclerosis III: Management
322
Management of atherosclerosis involves an integrated strategy encompassing pharmacological treatment, surgical interventions, lifestyle changes, and nutrition therapy to address the multifactorial nature of the disease.Pharmacological TherapyA cornerstone of atherosclerosis management is the use of pharmacological agents. Statins, such as atorvastatin, are pivotal in inhibiting HMG-CoA reductase, an enzyme that catalyzes an initial step in cholesterol synthesis in the liver. This reduction in...
322

